Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer
Abstract Background Most lung cancer patients worldwide (stage IV non-small cell lung cancer, NSCLC) have a poor survival: 25%-30% patients die < 3 months. Yet, of those surviving > 3 months, 10%-15% patients survive (very) long. Astragali radix (AR) is an effective traditional Chinese medicin...
Saved in:
Main Authors: | Wenke Xiao (Author), Yaxin Xu (Author), Jan P. Baak (Author), Jinrong Dai (Author), Lijia Jing (Author), Hongxia Zhu (Author), Yanxiong Gan (Author), Shichao Zheng (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the potential mechanism of radix astragali against ischemic stroke based on network pharmacology and molecular docking
by: Yang Zhen, et al.
Published: (2022) -
An Integrated Strategy for Effective-Component Discovery of Astragali Radix in the Treatment of Lung Cancer
by: Bing Yang, et al.
Published: (2021) -
Quality Markers for Astragali Radix and Its Products Based on Process Analysis
by: Yuntao Dai, et al.
Published: (2020) -
Structural Characterization and Immune Activity Screening of Polysaccharides With Different Molecular Weights From Astragali Radix
by: Ke Li, et al.
Published: (2020) -
Neuroprotective effect of Astragali Radix on cerebral infarction based on proteomics
by: Ying Li, et al.
Published: (2023)